News
The RADIOSA phase 2 randomised clinical trial included 102 patients with metachronic oligometastic prostate cancer who were randomly assigned to receive either stereotactic body radiotherapy (SBRT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback